Virtual Library

Start Your Search

  • WCLC 2019

    2019 World Conference on Lung Cancer

    Access to all presentations that occur during the 2019 World Conference on Lung Cancer in Barcelona, Spain

    Presentation Date(s):  
    • Sept 7 - 10, 2019
    • Total Presentations: 2848

    To review abstracts of the presentations below, narrow down your search by using the Filter options below, and then select the session listing of your choice. Click the "+" for a presentation to expand & view the corresponding Abstract details.

    Presentations will be available 24 hours after their live presentation time

Filter Results:

Show Only Available Presentations

  • +

    EXH01 - Bristol-Myers Squibb Foundation Exhibit Showcase Session - Adressing Inequities in Care and Support for Lung Cancer Patients In The Us and Africa: Lessons and Challenges From the Front Lines

    • Type: Industry Symposia & Workshops
    • Track:
    • Presentations: 0
    • Coordinates: 9/08/2019, 12:00 - 13:15, Exhibit Hall
    • +

      EXH01.01 - Registration & Lunch

      12:00 - 12:10

      • Abstract

      No abstract available for this presentation

    • +

      EXH01.02 - Host Opening Remarks

      12:10 - 12:13  |  Presenter: Catharine Grimes

      • Abstract

      No abstract available for this presentation

    • +

      EXH01.03 - Moderator Opening Remarks

      12:13 - 12:20  |  Presenter: Christopher S Lathan

      • Abstract

      No abstract available for this presentation

    • +

      EXH01.04 - Lung Cancer Screening: Are we ready? Educating providers and increasing awareness about their role in lung cancer screening. Lessons from the LuCa National Training Network in the US.

      12:20 - 12:28  |  Presenter: Celeste T Worth

      • Abstract

      No abstract available for this presentation

    • +

      EXH01.05 - Establishing a Pan-African collaboration to improve awareness about, data on and intervention for lung cancer. How Secure The Future is trying to rapidly build an African body of knowledge regarding lung cancer in different cultural and resource settings; health systems and within sites with varying risk-profiles and economic development

      12:28 - 12:36  |  Presenter: Fredrick Chite Asirwa

      • Abstract

      No abstract available for this presentation

    • +

      EXH01.06 - How do we track it? The VAPALS-ELCAP Open Source Lung Screening Management System: Implications for Global Partnerships to Improve Lung Screening Access, Safety, and Efficacy

      12:36 - 12:44  |  Presenter: Drew Moghanaki

      • Abstract

      No abstract available for this presentation

    • +

      EXH01.07 - Planning for Survivors: Building Support Services and Survivorship Pathways for Patients Treated for Lung Cancer

      12:44 - 12:52  |  Presenter: Scott Shofer

      • Abstract

      No abstract available for this presentation

    • +

      EXH01.08 - Putting it All Together - The Optimal Care Coordination Model (OCCM): The goal of this project is to create sustainable improvements in Medicaid patients’ access to quality lung cancer services and health outcomes by developing a comprehensive, written plan delineating a Medicaid lung cancer patient’s course of treatment and progression using an OCCM for providers, patients and their caregivers

      12:52 - 13:00  |  Presenter: Matthew P Smeltzer

      • Abstract

      No abstract available for this presentation

    • +

      EXH01.09 - Moderated Discussion and Q&A

      13:00 - 13:10  |  Presenter: Christopher S Lathan

      • Abstract

      No abstract available for this presentation

    • +

      EXH01.10 - Closing Remarks

      13:10 - 13:10  |  Presenter: Catharine Grimes

      • Abstract

      No abstract available for this presentation

  • +

    IS09 - Symposium by Physicians' Education Resource, LLC (PER): Leveraging The Lung Cancer Team In Stage III NSCLC With Immuno-Oncology Strategies (Not IASLC CME Accredited)

    • Type: Industry Symposia & Workshops
    • Track:
    • Presentations: 0
    • Coordinates: 9/08/2019, 12:00 - 13:30, Barcelona (2005)
  • +

    ES06 - New Approaches in Second Line Treatment In NSCLC

    • Type: Educational Session
    • Track: Advanced NSCLC
    • Presentations: 6
    • Now Available
    • Moderators:Susana Cedres
    • Coordinates: 9/08/2019, 13:30 - 15:00, Vienna (2016)
  • +

    ES07 - Thoracic Ultrasonography: Diagnosis and Staging

    • Type: Educational Session
    • Track: Interventional Diagnostics/Pulmonology
    • Presentations: 6
    • Now Available
    • Moderators:Felipe Andreo
    • Coordinates: 9/08/2019, 13:30 - 15:00, San Francisco (2009)
  • +

    ES08 - Critical Concerns in Screening

    • Type: Educational Session
    • Track: Screening and Early Detection
    • Presentations: 9
    • Now Available
    • Moderators:Ugo Pastorino
    • Coordinates: 9/08/2019, 13:30 - 15:00, Copenhagen (1980)
  • +

    ES09 - How I Do It - Real World Issues in the Diagnosis and Treatment of Metastatic NSCLC

    • Type: Educational Session
    • Track: Treatment in the Real World - Support, Survivorship, Systems Research
    • Presentations: 5
    • Now Available
    • Moderators:Margarida Dias
    • Coordinates: 9/08/2019, 13:30 - 15:00, Tokyo (1982)
    • +

      ES09.01 - How I Optimize Tissue Specimen Processing for Histopathological and Molecular Profiling (Now Available)

      13:30 - 13:45  |  Presenter: Amanjit Bal

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      ES09.02 - How I Report Imaging for Assessment of Responses to Targeted Therapies vs. Immune Checkpoint Inhibitors vs. Chemotherapy (Now Available)

      13:45 - 14:00  |  Presenter: Ritu R Gill

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      ES09.03 - How I Decide 1st Line Treatment Options for Metastatic NSCLC Without Driver Mutations - Balancing Efficacy, Toxicity and Cost (Now Available)

      14:00 - 14:15  |  Presenter: Martin NA Frueh

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      ES09.04 - How I Decide 2nd Line Treatment Options for Relapsed/Refractory Metastatic NSCLC (Now Available)

      14:15 - 14:30  |  Presenter: Navneet Singh

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      ES09.05 - Limitations in the Availability of Radiotherapy (Now Available)

      14:30 - 14:45  |  Presenter: Jamal Saleh Khader

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      ES09.06 - Q&A

      14:45 - 15:00

      • Abstract

      No abstract available for this presentation

  • +

    ES10 - Oncology Drug Approval: Challenges and Opportunities

    • Type: Educational Session
    • Track: Advanced NSCLC
    • Presentations: 6
    • Now Available
    • Moderators:Caicun Zhou
    • Coordinates: 9/08/2019, 13:30 - 15:00, Toronto (1985)
  • +

    GR01 - Whether and How to Adapt Treatment of NSCLC Oligometastatic Disease to…

    • Type: Grand Rounds Session
    • Track: Oligometastatic NSCLC
    • Presentations: 6
    • Now Available
    • Moderators:Jin-Soo Lee
    • Coordinates: 9/08/2019, 13:30 - 15:00, Seoul (2007)
  • +

    MA04 - Models and Biomarkers

    • Type: Mini Oral Session
    • Track: Biology
    • Presentations: 12
    • Now Available
  • +

    MA05 - Update on Clinical Trials and Treatments

    • Type: Mini Oral Session
    • Track: Mesothelioma
    • Presentations: 11
    • Now Available
    • Moderators:Seiki Hasegawa
    • Coordinates: 9/08/2019, 13:30 - 15:00, Melbourne (1991)
    • +

      MA05.01 - Second or Third Line Anti-PD-1 Therapy After Multimodality Therapy Including Total Pleurectomy in Malignant Pleural Mesothelioma (Now Available)

      13:30 - 13:35  |  Presenter: loic Lang-Lazdunski

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      MA05.02 - Log Odds of Positive Lymph Nodes Predicts Overall Survival and the Benefit of Postoperative Radiotherapy in Malignant Pleural Mesothelioma (Now Available)

      13:35 - 13:40  |  Presenter: Yang Wo

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      MA05.03 - Impact of Time to Surgery on Outcomes in Patients Undergoing Outright Resection for Malignant Pleural Mesothelioma (Now Available)

      13:40 - 13:45  |  Author(s): Soraya Voigt

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      MA05.04 - Discussant - MA05.01, MA05.02, MA05.03 (Now Available)

      13:45 - 14:00  |  Presenter: Clarissa Baldotto

      • Abstract
      • Presentation
      • Slides

      No abstract available for this presentation

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      MA05.05 - Post-Discontinuation Treatments in IFCT-GFPC-0701 MAPS Trial: Real-World Effectiveness of 2nd-Line (2L) Treatments for Mesothelioma (Now Available)

      14:00 - 14:05  |  Presenter: Gerard Zalcman

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      MA05.07 - Efficacy and Safety of Re-Treatment with Tremelimumab and Durvalumab Within the NIBIT-MESO-1 Study (Now Available)

      14:05 - 14:10  |  Presenter: Luana Calabro'

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      MA05.08 - Discussant - MA05.05, MA05.06, MA05.07 (Now Available)

      14:10 - 14:25  |  Presenter: James Spicer

      • Abstract
      • Presentation
      • Slides

      No abstract available for this presentation

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      MA05.09 - Real-World Data of Nivolumab and Pembrolizumab in Chemotherapy Pre-Treated Mesothelioma Patients (Now Available)

      14:25 - 14:30  |  Presenter: Daphne Dumoulin

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      MA05.10 - Pembrolizumab in the Treatment of Patients with Malignant Pleural Mesothelioma Following Progression After Initial Chemotherapy (Now Available)

      14:30 - 14:35  |  Presenter: Keith Cengel

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      MA05.11 - Safety and Efficacy of Nintedanib in Combination with Pembrolizumab in Patients with Refractory/Relapsing Malignant Pleural Mesothelioma (Now Available)

      14:35 - 14:40  |  Presenter: Andreea Varga

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      MA05.12 - Discussant - MA05.09, MA05.10, MA05.11 (Now Available)

      14:40 - 14:55  |  Presenter: Anna K Nowak

      • Abstract
      • Presentation
      • Slides

      No abstract available for this presentation

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      MA05.13 - Q&A

      14:55 - 15:00

      • Abstract

      No abstract available for this presentation